Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLG | P00747 | 1/20 | 0.50 |
| ▸ | PLAT | P00750 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | MMP12 | P39900 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 1/20 | 0.41 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.41 |
| ▸ | VCP | P55072 | 3/20 | 0.40 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL680677 | 1.00 | PLG (0.50) | PLGPLATLMNAKMT2ATDP1 | |
| Tranexamic Acid SCHEMBL2569232 | 0.91 | PLG (0.67) | PLGPLATLMNAKMT2ATDP1 | |
| SCHEMBL2340454 | 0.89 | PLG (0.42) | PLGPLATLMNAKMT2ATDP1 | |
| SCHEMBL22571032 | 0.89 | PLG (0.42) | PLGPLATLMNAKMT2ATDP1 | |
| SCHEMBL2340458 | 0.89 | PLG (0.42) | PLGPLATLMNAKMT2ATDP1 | |
| SCHEMBL2340457 | 0.89 | PLG (0.42) | PLGPLATLMNAKMT2ATDP1 | |
| SCHEMBL13165688 | 0.87 | TDP1 (0.58) | TDP1ALDH1A1SMN1; SMN2EPHX1CACNA1H | |
| SCHEMBL48633 | 0.87 | — | — | |
| SCHEMBL22721999 | 0.86 | TDP1 (0.48) | KMT2ATDP1ALDH1A1MEN1SMN1; SMN2 | |
| SCHEMBL12513444 | 0.86 | TDP1 (0.48) | KMT2ATDP1ALDH1A1MEN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025229086-A1 | ADHESIVE COSMETIC COMPOUNDS AND USES THEREOF | SKINOSIVE (FR) | 2025-11-06 | — | — | WO | claimed |
| CN-103172528-B | Tranexamic acid preparation method | :YANTAI VALIANT FINE CHEMICALS CO., LTD. (CN) | 2014-10-08 | — | — | CN | claimed |
| JP-7233041-A | — | — | None | — | — | JP | disclosed |
| JP-7233090-A | — | — | None | — | — | JP | disclosed |
| WO-2025229086-A1 | ADHESIVE COSMETIC COMPOUNDS AND USES THEREOF | SKINOSIVE (FR) | 2025-11-06 | — | — | WO | disclosed |
| WO-2024080290-A1 | MELANIN PIGMENT SYNTHESIS INHIBITOR | 一丸ファルコス株式会社 | 2024-04-18 | — | — | WO | disclosed |
| US-20230159455-A1 | DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS | SENSORIUM THERAPEUTICS, INC. | 2023-05-25 | — | — | US | disclosed |
| CN-113631144-A | Cosmetic containing ultraviolet wavelength conversion substance and medicinal agent | 株式会社资生堂 | 2021-11-09 | — | — | CN | disclosed |
| WO-2021064189-A2 | PROSTAGLANDIN E2 (PGE2) EP4 RECEPTOR ANTAGONISTS | DOMAIN THERAPEUTICS (FR) | 2021-04-08 | — | — | WO | disclosed |
| WO-2020204191-A1 | COSMETIC CONTAINING ULTRAVIOLET WAVELENGTH CONVERSION SUBSTANCE AND MEDICINAL AGENT | 株式会社 資生堂 | 2020-10-08 | — | — | WO | disclosed |
| CN-102300839-B | Method For Manufacturing Trans-{4-[(alkyl Amino) Methyl] Cyclohexyl} Acetic Ester | KOWA CO | 2014-12-10 | — | — | CN | disclosed |
| EP-1466625-A1 | PREVENTIVES/REMEDIES FOR URINARY DISTURBANCE | Takeda Chemical Industries, Ltd. (JP) | 2004-10-13 | — | — | EP | disclosed |
| EP-0585130-B1 | External preparation for skin containing a depigmentation agent | SHISEIDO CO LTD (JP) | 1998-01-28 | — | — | EP | disclosed |
| US-5690914-A | TRANEXAMIC ACID DERIVATIVES FOR DEPIGMENTATION | SHISEIDO CO., LTD (JP) | 1997-11-25 | — | — | US | disclosed |
| JP-H07233090-A | EXTERNAL AGENT FOR SKIN | SHISEIDO CO LTD | 1995-09-05 | — | — | JP | disclosed |
| JP-H07233041-A | SKIN EXTERNAL PREPARATION | SHISEIDO CO LTD | 1995-09-05 | — | — | JP | disclosed |
| EP-0585130-A2 | External preparation for skin containing a depigmentation agent | SHISEIDO COMPANY LIMITED (JP) | 1994-03-02 | — | — | EP | disclosed |
| US-4267174-A | AND PROCESS FOR ADMINISTERING | BOEHRINGER MANNHEIM, GMBH (DE) | 1981-05-12 | — | — | US | disclosed |
| US-4081541-A | Steroid derivatives | RORER ITALIANA S.P.A. (IT) | 1978-03-28 | — | — | US | disclosed |
| US-4011317-A | STEROID DERIVATIVES | RORER ITALIANA S.P.A. (IT) | 1977-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159455-A1 | DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS | PNMT, HNMT, NNMT | PLG 917/4885PLAT 1281/4885LMNA 1333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.